Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$3.0350
+0.0350 ( -0.82% ) 1.4M
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$3.0350
Previous close
$3.0000
Volume
1.4M
Market cap
$204.45M
Day range
$2.9580 - $3.1790
52 week range
$2.2800 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Feb 01, 2024 |
4 | Insider transactions | 1 | Feb 01, 2024 |
4 | Insider transactions | 1 | Jan 30, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
8-k | 8K-related | 21 | Jan 22, 2024 |
8-k | 8K-related | 13 | Jan 17, 2024 |
8-k/a | 8K-related | 16 | Jan 17, 2024 |
8-k | 8K-related | 15 | Jan 17, 2024 |
8-k | 8K-related | 100 | Jan 17, 2024 |